.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Teva
Novartis
McKesson
Johnson and Johnson
AstraZeneca
Fuji
Federal Trade Commission
Moodys

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076130

« Back to Dashboard
NDA 076130 describes VOSPIRE ER, which is a drug marketed by Dava Pharms Inc and is included in one NDA. It is available from one supplier. Additional details are available on the VOSPIRE ER profile page.

The generic ingredient in VOSPIRE ER is albuterol sulfate. There are thirty-seven drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

Summary for NDA: 076130

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 076130

Mechanism of ActionAdrenergic beta2-Agonists

Suppliers and Packaging for NDA: 076130

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VOSPIRE ER
albuterol sulfate
 TABLET, EXTENDED RELEASE;ORAL 076130 ANDA DAVA Pharmaceuticals, Inc. 68774-400 68774-400-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68774-400-01)
VOSPIRE ER
albuterol sulfate
 TABLET, EXTENDED RELEASE;ORAL 076130 ANDA DAVA Pharmaceuticals, Inc. 68774-401 68774-401-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68774-401-01)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 4MG BASE
Approval Date:Sep 26, 2002TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 8MG BASE
Approval Date:Sep 26, 2002TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Express Scripts
Teva
Federal Trade Commission
Healthtrust
Chubb
Chinese Patent Office
Cerilliant
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot